Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 1
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP.
Davis J, Yan S, Matsushita T, Alberio L, Bassett P, Santagostino E. Davis J, et al. J Med Econ. 2019 Oct;22(10):1014-1021. doi: 10.1080/13696998.2019.1620246. Epub 2019 Jun 5. J Med Econ. 2019. PMID: 31094591 Free article.
A systematic review and indirect statistical comparison was performed to evaluate the efficacy of both EHL and standard-acting rFIX products compared with rIX-FP in Phase III trials for prophylaxis in adult hemophilia B patients. Materials and methods: A systematic …
A systematic review and indirect statistical comparison was performed to evaluate the efficacy of both EHL and standard-acting rFIX products …
Outcome measures in haemophilia: a systematic review.
Boehlen F, Graf L, Berntorp E. Boehlen F, et al. Eur J Haematol Suppl. 2014 Aug;76:2-15. doi: 10.1111/ejh.12369. Eur J Haematol Suppl. 2014. PMID: 24957102 Review.
Outcome measurements in persons with haemophilia (PWH) have been limited to laboratory evaluation (factor VIII or IX levels) and clinical outcomes (such as bleeding frequency), morbidity (for example linked with arthropathy) and mortality. ...
Outcome measurements in persons with haemophilia (PWH) have been limited to laboratory evaluation (factor VIII or IX levels) and clin …
Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.
Boehnel C, Rickli H, Graf L, Maeder MT. Boehnel C, et al. Catheter Cardiovasc Interv. 2018 Jul;92(1):1-15. doi: 10.1002/ccd.27255. Epub 2017 Sep 12. Catheter Cardiovasc Interv. 2018. PMID: 28895303
BACKGROUND: Hemophilia patients undergoing coronary angiography and PCI are at risk of bleeding due to deficiency of the essential clotting factors VIII or IX combined with the need of peri-interventional anticoagulation and antiaggregation and dual antiplatelet therapy (DAPT) af …
BACKGROUND: Hemophilia patients undergoing coronary angiography and PCI are at risk of bleeding due to deficiency of the essential clotting …
Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors: a systematic literature review.
Hart DP, Hay CRM, Liesner R, Tobaruela G, Du-Mont B, Makris M. Hart DP, et al. Blood Coagul Fibrinolysis. 2019 Oct;30(7):309-323. doi: 10.1097/MBC.0000000000000840. Blood Coagul Fibrinolysis. 2019. PMID: 31397688 Free article.
The identified studies were screened again to find articles reporting perioperative laboratory monitoring in patients with congenital haemophilia A or B, resulting in 24 articles undergoing data extraction. ...
The identified studies were screened again to find articles reporting perioperative laboratory monitoring in patients with congenital …